Acme Universal IPO
Founded in November 2016, Acme Universal Safezone 9 operates in the Personal Protective Equipment (PPE) segment, manufacturing safety shoes and industrial footwear that protect workers from compression, penetration, electrical shock, static electricity, heat and fire, chemicals, and slipping. Its products cater to a wide range of industries, including construction, oil and gas, mining, heavy engineering, automotive, pharmaceuticals, chemical processing, foundry, and power generation.
IPO GMP
+₹10
+14% expected gain
Price Band
₹71
Lot Size
3200 shares
Min Investment
₹2,27,200
Listing Date
October 6, 2026
About Acme Universal
Company overview, business, and key facts.
Founded in November 2016, Acme Universal Safezone 9 operates in the Personal Protective Equipment (PPE) segment, manufacturing safety shoes and industrial footwear that protect workers from compression, penetration, electrical shock, static electricity, heat and fire, chemicals, and slipping. Its products cater to a wide range of industries, including construction, oil and gas, mining, heavy engineering, automotive, pharmaceuticals, chemical processing, foundry, and power generation.
Acme Universal provides 15 different types of products across EVA rubber, nitrile rubber, and PVC sole types. The company operates its 4 manufacturing facilities in Madhya Pradesh and Uttar Pradesh. Moreover, it supplies its products through direct institutional sales, distributors and dealers, and e-commerce channels. Furthermore, the company also exports its products to the UAE, Bahrain, Saudi Arabia, Nigeria, Israel, the Netherlands, Hong Kong, Cameroon and Mauritius.
Founded
2016
Headquarters
Gwalior, Madhya Pradesh
Promoters
Nitin Tiwari, Ruchi Tiwari
Website
https://www.acmeuniversal9.com/
IPO Details
Subscription Status
How many times each investor category has bid for the issue.
Financials
Restated summary financials for the most recent periods.
Figures are indicative and restated for presentation.
Acme Universal IPO Key Numbers
Calculated by IPOLyst from the published offer-document data. These are figures, not buy or sell calls.
Market cap at upper band
₹135.6 Cr
Post-IPO shares × upper price band
P/E on 2026 profit
23.1x
Peer median 40.8x (discount of 43.4%)
Price to sales
0.64x
Revenue growth, 2026
+10.4%
7.8% a year over the period
Profit growth, 2026
+632.5%
-12% a year over the period
Profit margin (PAT)
2.8%
EBITDA margin 7.36%
ROE / ROCE
11.75% / 5.54%
As published in the offer document
Debt to equity
1.1
Promoter holding
94.88% → 69.73%
Before → after the IPO
Issue mix
100% fresh / 0% sale
Fresh issue goes to the company, offer for sale to selling shareholders
GMP-implied gain per lot
₹32,000
3200 shares on ₹2,27,200. GMP is unofficial.
What stands out
- Profit grew 632.5% in 2026.
- Priced at a 43.4% discount to the peer median P/E of 40.8.
- GMP has been rising over the last three readings.
Watch-outs
- Thin profit margin: PAT margin was 2.8% in 2026.
- Leverage: debt to equity is 1.1.
- 1 use-of-proceeds item(s) have no disclosed amount.
Scenarios apply today's grey market premium figures to the upper price band. They are illustrations, not predictions. GMP is unofficial and can be wrong.
Not yet available for this IPO: published risk factors.
IPO Analysis SummaryAI-generated
A plain-language review of Acme Universal's financials, valuation and demand, based only on the verified figures above. For information only. It does not recommend whether to apply.
Acme Universal IPO Review
Analysis based on live GMP, subscription, and issue details.
As of today, Acme Universal IPO is trading at a grey market premium (GMP) of +₹10 (+14% estimated listing gain), indicating positive market sentiment.
The IPO has been subscribed 14.72x overall — QIB: 12.52x, NII: 23.64x, Retail: 12.66x.
Acme Universal IPO subscription has closed. The shares are expected to list on October 6, 2026.
The minimum investment required is ₹2,27,200 for 3200 shares (1 lot). Retail investors can apply at cut-off price for the best chance of allotment.
Disclaimer: IPO GMP is indicative and sourced from the grey market. This is not investment advice. Please consult a SEBI-registered advisor before investing.
Acme Universal IPO — Frequently Asked Questions
What is Acme Universal IPO GMP today?
Acme Universal IPO GMP (grey market premium) today is +₹10, suggesting an estimated listing gain of +14%. GMP is indicative and subject to change.
What is the price band of Acme Universal IPO?
The price band for Acme Universal IPO is ₹71 with a lot size of 3200 shares. The minimum investment required is ₹2,27,200.
When is Acme Universal IPO allotment date?
Acme Universal IPO allotment is expected to be finalised on October 1, 2026. You can check your allotment status on the registrar's website (Maashitla Securities Pvt. Ltd.) using your PAN number.
When will Acme Universal IPO list on NSE/BSE?
Acme Universal IPO is expected to list on BSE SME on October 6, 2026.
How to check Acme Universal IPO allotment status?
To check Acme Universal IPO allotment status, visit the registrar's website (Maashitla Securities Pvt. Ltd.) and enter your PAN number, application number, or DP/Client ID. You can also check on the BSE IPO allotment page at https://www.bseindia.com/investors/appli_check.aspx.
Should I apply for Acme Universal IPO?
Acme Universal IPO has a GMP of +₹10. Before applying, review the company's financials, business model, issue structure (OFS vs fresh issue), and sector outlook. IPOLyst is not a SEBI-registered investment advisor — please consult a qualified financial advisor before investing.
What is the lot size of Acme Universal IPO?
The lot size for Acme Universal IPO is 3200 shares per lot. The minimum investment for retail investors is ₹2,27,200. Retail investors can apply for a maximum of 13 lots or up to ₹2 lakh, whichever is lower.